Auxogyn Press Releases


  • April 21, 2015

    Announcing Progyny: Combining Best-in-Class Clinical Solutions with Consumer Expertise

    Progyny Raises New Round to Fund Clinical Solutions that Improve Patient Outcomes Progyny, Inc., the new combined entity of Auxogyn, Inc. and Fertility Authority, LLC, announced that it has secured additional capital from investors including Kleiner Perkins Caufield & Byers (KPCB), TPG Biotech, SR One and Merck Serono Ventures. The funding will enable the companyFull story >>... Full Story

  • March 26, 2015

    The Eeva™ Test is Now Available to Help IVF Patients in the United States

    First and Only Non-invasive, Predictive Test to Aid in Embryo Selection March 26, 2015, NEW YORK, NY – The Eeva Test is now commercially available in the United States following its recent FDA clearance.   This breakthrough technology is designed to help fertility clinics select the best embryos during in vitro fertilization (IVF) to aid in theirFull story >>... Full Story

  • March 12, 2015

    Auxogyn and Fertility Authority to Merge

    Auxogyn, Inc. and Fertility Authority, LLC today announced the merger of the two companies. The combined company will be the first to provide fertility patients with easy accessibility to high quality doctors, price transparency and financing, extraordinary clinical expertise, and proprietary clinical solutions under one roof.... Full Story






  • October 4, 2010

    Auxogyn Licenses Non-Invasive Embryo Assessment Technology from Stanford University

    Auxogyn, Inc., a privately held medical technology company focused on women’s reproductive health, today announced that it acquired an exclusive license from Stanford University to develop a set of products that may allow medical practitioners in the field of assisted reproduction to significantly improve the effectiveness of in vitro fertilization (IVF) procedures... Full Story